Quantitative CT Texture Analysis of COVID-19 Hospitalized Patients during 3-24-Month Follow-Up and Correlation with Functional Parameters.

COVID-19 pneumonia CT follow-up lung machine learning quantitative computed tomography texture analysis

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
05 Mar 2024
Historique:
received: 25 01 2024
revised: 21 02 2024
accepted: 27 02 2024
medline: 13 3 2024
pubmed: 13 3 2024
entrez: 13 3 2024
Statut: epublish

Résumé

To quantitatively evaluate CT lung abnormalities in COVID-19 survivors from the acute phase to 24-month follow-up. Quantitative CT features as predictors of abnormalities' persistence were investigated. Patients who survived COVID-19 were retrospectively enrolled and underwent a chest CT at baseline (T0) and 3 months (T3) after discharge, with pulmonary function tests (PFTs). Patients with residual CT abnormalities repeated the CT at 12 (T12) and 24 (T24) months after discharge. A machine-learning-based software, CALIPER, calculated the CT percentage of the whole lung of normal parenchyma, ground glass (GG), reticulation (Ret), and vascular-related structures (VRSs). Differences (Δ) were calculated between time points. Receiver operating characteristic (ROC) curve analyses were performed to test the baseline parameters as predictors of functional impairment at T3 and of the persistence of CT abnormalities at T12. The cohort included 128 patients at T0, 133 at T3, 61 at T12, and 34 at T24. The GG medians were 8.44%, 0.14%, 0.13% and 0.12% at T0, T3, T12 and T24. The Ret medians were 2.79% at T0 and 0.14% at the following time points. All Δ significantly differed from 0, except between T12 and T24. The GG and VRSs at T0 achieved AUCs of 0.73 as predictors of functional impairment, and area under the curves (AUCs) of 0.71 and 0.72 for the persistence of CT abnormalities at T12. CALIPER accurately quantified the CT changes up to the 24-month follow-up. Resolution mostly occurred at T3, and Ret persisting at T12 was almost unchanged at T24. The baseline parameters were good predictors of functional impairment at T3 and of abnormalities' persistence at T12.

Sections du résumé

BACKGROUND BACKGROUND
To quantitatively evaluate CT lung abnormalities in COVID-19 survivors from the acute phase to 24-month follow-up. Quantitative CT features as predictors of abnormalities' persistence were investigated.
METHODS METHODS
Patients who survived COVID-19 were retrospectively enrolled and underwent a chest CT at baseline (T0) and 3 months (T3) after discharge, with pulmonary function tests (PFTs). Patients with residual CT abnormalities repeated the CT at 12 (T12) and 24 (T24) months after discharge. A machine-learning-based software, CALIPER, calculated the CT percentage of the whole lung of normal parenchyma, ground glass (GG), reticulation (Ret), and vascular-related structures (VRSs). Differences (Δ) were calculated between time points. Receiver operating characteristic (ROC) curve analyses were performed to test the baseline parameters as predictors of functional impairment at T3 and of the persistence of CT abnormalities at T12.
RESULTS RESULTS
The cohort included 128 patients at T0, 133 at T3, 61 at T12, and 34 at T24. The GG medians were 8.44%, 0.14%, 0.13% and 0.12% at T0, T3, T12 and T24. The Ret medians were 2.79% at T0 and 0.14% at the following time points. All Δ significantly differed from 0, except between T12 and T24. The GG and VRSs at T0 achieved AUCs of 0.73 as predictors of functional impairment, and area under the curves (AUCs) of 0.71 and 0.72 for the persistence of CT abnormalities at T12.
CONCLUSIONS CONCLUSIONS
CALIPER accurately quantified the CT changes up to the 24-month follow-up. Resolution mostly occurred at T3, and Ret persisting at T12 was almost unchanged at T24. The baseline parameters were good predictors of functional impairment at T3 and of abnormalities' persistence at T12.

Identifiants

pubmed: 38473022
pii: diagnostics14050550
doi: 10.3390/diagnostics14050550
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Salvatore Claudio Fanni (SC)

Department of Translational Research, Academic Radiology, University of Pisa, 56126 Pisa, Italy.

Federica Volpi (F)

Department of Translational Research, Academic Radiology, University of Pisa, 56126 Pisa, Italy.

Leonardo Colligiani (L)

Department of Translational Research, Academic Radiology, University of Pisa, 56126 Pisa, Italy.

Davide Chimera (D)

Pneumology Unit, Pisa University Hospital, 56124 Pisa, Italy.

Michele Tonerini (M)

Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, 56124 Pisa, Italy.

Francesco Pistelli (F)

Pneumology Unit, Pisa University Hospital, 56124 Pisa, Italy.

Roberta Pancani (R)

Pneumology Unit, Pisa University Hospital, 56124 Pisa, Italy.

Chiara Airoldi (C)

Department of Translational Medicine, University of Eastern Piemonte, 28100 Novara, Italy.

Brian J Bartholmai (BJ)

Division of Radiology, Mayo Clinic, Rochester, MN 55905, USA.

Dania Cioni (D)

Department of Translational Research, Academic Radiology, University of Pisa, 56126 Pisa, Italy.

Laura Carrozzi (L)

Pneumology Unit, Pisa University Hospital, 56124 Pisa, Italy.

Emanuele Neri (E)

Department of Translational Research, Academic Radiology, University of Pisa, 56126 Pisa, Italy.

Annalisa De Liperi (A)

2nd Radiology Unit, Department of Diagnostic Imaging, Pisa University-Hospital, Via Paradisa 2, 56124 Pisa, Italy.

Chiara Romei (C)

2nd Radiology Unit, Department of Diagnostic Imaging, Pisa University-Hospital, Via Paradisa 2, 56124 Pisa, Italy.

Classifications MeSH